US EditionBrainomix closes a £14 million ($18 million) Series C round to advance its transformative AI imaging technology in healthcare
Summary by bionity.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
All
Left
Center
Right
bionity.comReposted by 
analytica-world.com
analytica-world.comBrainomix closes a £14 million ($18 million) Series C round to advance its transformative AI imaging technology in healthcare
Brainomix, a company developing AI-powered imaging tools for stroke and pulmonary fibrosis, announced the completion of a GBP 14 million (USD 18 million) Series C investment round. The round is led by prominent health technology investors, including the...
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
